Search research articles
Contact Us
Filters
Showing results (21-30 of 33) with videos related to
Page
of 4
Sort By:
Stroke
|
May 9, 2015
Common NOTCH3 Variants and Cerebral Small-Vessel Disease
Loes C A Rutten-Jacobs, Matthew Traylor, Poneh Adib-Samii, et al.
Stroke
|
February 4, 2016
Association of MTHFR C677T Genotype With Ischemic Stroke Is Confined to Cerebral Small Vessel Disease Subtype
Loes C A Rutten-Jacobs, Matthew Traylor, Poneh Adib-Samii, et al.
Clinical Science (London, England : 1979)
|
May 11, 2017
Using DTI to assess white matter microstructure in cerebral small vessel disease (SVD) in multicentre studies
Iain D Croall, Valerie Lohner, Barry Moynihan, et al.
JAMA Neurology
|
May 24, 2023
Isosorbide Mononitrate and Cilostazol Treatment in Patients With Symptomatic Cerebral Small Vessel Disease: The Lacunar Intervention Trial-2 (LACI-2) Randomized Clinical Trial
Joanna M Wardlaw, Lisa J Woodhouse, Iris I Mhlanga, et al.
Journal of Neurology, Neurosurgery, and Psychiatry
|
November 6, 2020
Characteristics and outcomes of COVID-19 associated stroke: a UK multicentre case-control study
Richard J Perry, Craig J Smith, Christine Roffe, et al.
Plos One
|
February 7, 2023
Atrial fibrillation in UK South Asian hospitalized ischemic stroke patients: The BRAINS study
Taylor Aurelius, Gie Ken-Dror, Sapna D Sharma, et al.
European Journal of Neurology
|
October 19, 2022
Ischaemic stroke in South Asians: The BRAINS study
Taylor Aurelius, Ankita Maheshwari, Gie Ken-Dror, et al.
Journal of Human Hypertension
|
March 4, 2024
Allopurinol and blood pressure variability following ischemic stroke and transient ischemic attack: a secondary analysis of XILO-FIST
Alexander S Macdonald, Alex McConnachie, David Alexander Dickie, et al.
Eclinicalmedicine
|
March 3, 2023
Xanthine oxidase inhibition and white matter hyperintensity progression following ischaemic stroke and transient ischaemic attack (XILO-FIST): a multicentre, double-blinded, randomised, placebo-controlled trial
Jesse Dawson, Michele Robertson, David Alexander Dickie, et al.
The Lancet. Neurology
|
October 18, 2024
Tenecteplase versus alteplase for acute stroke within 4·5 h of onset (ATTEST-2): a randomised, parallel group, open-label trial
Keith W Muir, Gary A Ford, Ian Ford, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 33) with videos related to
Sort By:
Page
of 4
Stroke
|
May 9, 2015
Common NOTCH3 Variants and Cerebral Small-Vessel Disease
Loes C A Rutten-Jacobs, Matthew Traylor, Poneh Adib-Samii, et al.
Stroke
|
February 4, 2016
Association of MTHFR C677T Genotype With Ischemic Stroke Is Confined to Cerebral Small Vessel Disease Subtype
Loes C A Rutten-Jacobs, Matthew Traylor, Poneh Adib-Samii, et al.
Clinical Science (London, England : 1979)
|
May 11, 2017
Using DTI to assess white matter microstructure in cerebral small vessel disease (SVD) in multicentre studies
Iain D Croall, Valerie Lohner, Barry Moynihan, et al.
JAMA Neurology
|
May 24, 2023
Isosorbide Mononitrate and Cilostazol Treatment in Patients With Symptomatic Cerebral Small Vessel Disease: The Lacunar Intervention Trial-2 (LACI-2) Randomized Clinical Trial
Joanna M Wardlaw, Lisa J Woodhouse, Iris I Mhlanga, et al.
Journal of Neurology, Neurosurgery, and Psychiatry
|
November 6, 2020
Characteristics and outcomes of COVID-19 associated stroke: a UK multicentre case-control study
Richard J Perry, Craig J Smith, Christine Roffe, et al.
Plos One
|
February 7, 2023
Atrial fibrillation in UK South Asian hospitalized ischemic stroke patients: The BRAINS study
Taylor Aurelius, Gie Ken-Dror, Sapna D Sharma, et al.
European Journal of Neurology
|
October 19, 2022
Ischaemic stroke in South Asians: The BRAINS study
Taylor Aurelius, Ankita Maheshwari, Gie Ken-Dror, et al.
Journal of Human Hypertension
|
March 4, 2024
Allopurinol and blood pressure variability following ischemic stroke and transient ischemic attack: a secondary analysis of XILO-FIST
Alexander S Macdonald, Alex McConnachie, David Alexander Dickie, et al.
Eclinicalmedicine
|
March 3, 2023
Xanthine oxidase inhibition and white matter hyperintensity progression following ischaemic stroke and transient ischaemic attack (XILO-FIST): a multicentre, double-blinded, randomised, placebo-controlled trial
Jesse Dawson, Michele Robertson, David Alexander Dickie, et al.
The Lancet. Neurology
|
October 18, 2024
Tenecteplase versus alteplase for acute stroke within 4·5 h of onset (ATTEST-2): a randomised, parallel group, open-label trial
Keith W Muir, Gary A Ford, Ian Ford, et al.
Page
of 4